BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shirasaka Y, Kuraoka E, Spahn-Langguth H, Nakanishi T, Langguth P, Tamai I. Species difference in the effect of grapefruit juice on intestinal absorption of talinolol between human and rat. J Pharmacol Exp Ther 2010;332:181-9. [PMID: 19779132 DOI: 10.1124/jpet.109.159756] [Cited by in Crossref: 100] [Cited by in F6Publishing: 101] [Article Influence: 7.7] [Reference Citation Analysis]
Number Citing Articles
1 Asaumi R, Nunoya K, Yamaura Y, Taskar KS, Sugiyama Y. Robust physiologically based pharmacokinetic model of rifampicin for predicting drug–drug interactions via P‐glycoprotein induction and inhibition in the intestine, liver, and kidney. CPT Pharmacom & Syst Pharma 2022;11:919-933. [DOI: 10.1002/psp4.12807] [Reference Citation Analysis]
2 Masuo Y, Futatsugi A, Kato Y. EXPERIMENTAL APPROACHES FOR STUDYING DRUG TRANSPORTERS. In: You G, Morris ME, editors. Drug Transporters. Wiley; 2022. pp. 413-31. [DOI: 10.1002/9781119739883.ch20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Stouras I, Papaioannou TG, Tsioufis K, Eliopoulos AG, Sanoudou D. The Challenge and Importance of Integrating Drug-Nutrient-Genome Interactions in Personalized Cardiovascular Healthcare. J Pers Med 2022;12:513. [PMID: 35455629 DOI: 10.3390/jpm12040513] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Funai Y, Takemura M, Inoue K, Shirasaka Y. Effect of Ingested Fluid Volume and Solution Osmolality on Intestinal Drug Absorption: Impact on Drug Interaction with Beverages. Eur J Pharm Sci 2022;:106136. [PMID: 35121020 DOI: 10.1016/j.ejps.2022.106136] [Reference Citation Analysis]
5 Shirasaka Y, Seki M, Hatakeyama M, Kurokawa Y, Uchiyama H, Takemura M, Yasugi Y, Kishimoto H, Tamai I, Wang J, Inoue K. Multiple Transport Mechanisms Involved in the Intestinal Absorption of Metformin: Impact on the Nonlinear Absorption Kinetics. Journal of Pharmaceutical Sciences 2022. [DOI: 10.1016/j.xphs.2022.01.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wang X, Zhang Y, Yang H, Xu Y. Maternal-fetal transfer of indocyanine green: a systematic review. J Matern Fetal Neonatal Med 2021;:1-5. [PMID: 34565270 DOI: 10.1080/14767058.2021.1966410] [Reference Citation Analysis]
7 Elmeliegy M, Vourvahis M, Guo C, Wang DD. Effect of P-glycoprotein (P-gp) Inducers on Exposure of P-gp Substrates: Review of Clinical Drug-Drug Interaction Studies. Clin Pharmacokinet 2020;59:699-714. [PMID: 32052379 DOI: 10.1007/s40262-020-00867-1] [Cited by in Crossref: 79] [Cited by in F6Publishing: 84] [Article Influence: 79.0] [Reference Citation Analysis]
8 Miyake T, Tsutsui H, Haraya K, Tachibana T, Morimoto K, Takehara S, Ayabe M, Kobayashi K, Kazuki Y. Quantitative prediction of P-glycoprotein-mediated drug-drug interactions and intestinal absorption using humanized mice. Br J Pharmacol 2021. [PMID: 34232502 DOI: 10.1111/bph.15612] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Shimazaki S, Kuroda J, Shimomura K, Misaka S. Urinary Excretion of Nadolol as a Possible In Vivo Probe for Drug Interactions Involving P-Glycoprotein. J Clin Pharmacol 2021;61:799-805. [PMID: 33387374 DOI: 10.1002/jcph.1812] [Reference Citation Analysis]
10 Domínguez CJ, Tocchetti GN, Rigalli JP, Mottino AD. Acute regulation of apical ABC transporters in the gut. Potential influence on drug bioavailability. Pharmacol Res 2021;163:105251. [PMID: 33065282 DOI: 10.1016/j.phrs.2020.105251] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
11 Al-ali AAA, Sandra L, Versweyveld D, Pijpers I, Dillen L, Vermeulen A, Snoeys J, Holm R, Nielsen CU. High-dose etoposide formulations do not saturate intestinal P-glycoprotein: Development, stability, and pharmacokinetics in Sprague-Dawley rats. International Journal of Pharmaceutics 2020;583:119399. [DOI: 10.1016/j.ijpharm.2020.119399] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Suzuki S, Shirasaka Y, Okada R, Eguchi A, Kishimoto H, Langguth P, Inoue K. Quantitative analysis of the effect of controlled-release formulation on nonlinear gastrointestinal absorption of P-glycoprotein substrate talinolol using physiologically based pharmacokinetic absorption model. Journal of Drug Delivery Science and Technology 2020;56:101057. [DOI: 10.1016/j.jddst.2019.05.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Murakami T, Bodor E, Bodor N. Modulation of expression/function of intestinal P-glycoprotein under disease states. Expert Opinion on Drug Metabolism & Toxicology 2020;16:59-78. [DOI: 10.1080/17425255.2020.1701653] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
14 Dubbelboer I, Dahlgren D, Sjögren E, Lennernäs H. Rat intestinal drug permeability: A status report and summary of repeated determinations. European Journal of Pharmaceutics and Biopharmaceutics 2019;142:364-76. [DOI: 10.1016/j.ejpb.2019.07.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
15 Oswald S. Organic Anion Transporting Polypeptide (OATP) transporter expression, localization and function in the human intestine. Pharmacology & Therapeutics 2019;195:39-53. [DOI: 10.1016/j.pharmthera.2018.10.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 9.7] [Reference Citation Analysis]
16 Funai Y, Shirasaka Y, Ishihara M, Takemura M, Ichijo K, Kishimoto H, Inoue K. Effect of Osmolality on the Pharmacokinetic Interaction between Apple Juice and Atenolol in Rats. Drug Metab Dispos 2019;47:386-91. [DOI: 10.1124/dmd.118.084483] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
17 Schäfer AM, Bock T, Meyer zu Schwabedissen HE. Establishment and Validation of Competitive Counterflow as a Method To Detect Substrates of the Organic Anion Transporting Polypeptide 2B1. Mol Pharmaceutics 2018;15:5501-13. [DOI: 10.1021/acs.molpharmaceut.8b00631] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
18 Meyer zu Schwabedissen HE, Ferreira C, Schaefer AM, Oufir M, Seibert I, Hamburger M, Tirona RG. Thyroid Hormones Are Transport Substrates and Transcriptional Regulators of Organic Anion Transporting Polypeptide 2B1. Mol Pharmacol 2018;94:700-12. [DOI: 10.1124/mol.117.111161] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
19 Ivanyuk A, Livio F, Biollaz J, Buclin T. Renal Drug Transporters and Drug Interactions. Clin Pharmacokinet 2017;56:825-92. [PMID: 28210973 DOI: 10.1007/s40262-017-0506-8] [Cited by in Crossref: 116] [Cited by in F6Publishing: 90] [Article Influence: 29.0] [Reference Citation Analysis]
20 Ayehunie S, Landry T, Stevens Z, Armento A, Hayden P, Klausner M. Human Primary Cell-Based Organotypic Microtissues for Modeling Small Intestinal Drug Absorption. Pharm Res 2018;35:72. [PMID: 29476278 DOI: 10.1007/s11095-018-2362-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 8.0] [Reference Citation Analysis]
21 Karibe T, Imaoka T, Abe K, Ando O. Curcumin as an In Vivo Selective Intestinal Breast Cancer Resistance Protein Inhibitor in Cynomolgus Monkeys. Drug Metab Dispos 2018;46:667-79. [PMID: 29358184 DOI: 10.1124/dmd.117.078931] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
22 Čvorović J, Ziberna L, Fornasaro S, Tramer F, Passamonti S. Bioavailability of Flavonoids: The Role of Cell Membrane Transporters. Polyphenols: Mechanisms of Action in Human Health and Disease. Elsevier; 2018. pp. 295-320. [DOI: 10.1016/b978-0-12-813006-3.00022-2] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
23 Yu J, Zhou Z, Tay-sontheimer J, Levy RH, Ragueneau-majlessi I. Intestinal Drug Interactions Mediated by OATPs: A Systematic Review of Preclinical and Clinical Findings. Journal of Pharmaceutical Sciences 2017;106:2312-25. [DOI: 10.1016/j.xphs.2017.04.004] [Cited by in Crossref: 77] [Cited by in F6Publishing: 77] [Article Influence: 15.4] [Reference Citation Analysis]
24 Li Y, Revalde J, Paxton JW. The effects of dietary and herbal phytochemicals on drug transporters. Adv Drug Deliv Rev 2017;116:45-62. [PMID: 27637455 DOI: 10.1016/j.addr.2016.09.004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 6.6] [Reference Citation Analysis]
25 Khuri N, Zur AA, Wittwer MB, Lin L, Yee SW, Sali A, Giacomini KM. Computational Discovery and Experimental Validation of Inhibitors of the Human Intestinal Transporter OATP2B1. J Chem Inf Model 2017;57:1402-13. [PMID: 28562037 DOI: 10.1021/acs.jcim.6b00720] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
26 Impact of Influx Transporters on Drug Absorption. Oral Bioavailability Assessment 2017. [DOI: 10.1002/9781118916926.ch7] [Reference Citation Analysis]
27 Impact of Intestinal Efflux Transporters on Oral Absorption. Oral Bioavailability Assessment 2017. [DOI: 10.1002/9781118916926.ch6] [Reference Citation Analysis]
28 Mimura Y, Yasujima T, Ohta K, Inoue K, Yuasa H. Functional Identification of Plasma Membrane Monoamine Transporter (PMAT/SLC29A4) as an Atenolol Transporter Sensitive to Flavonoids Contained in Apple Juice. J Pharm Sci 2017;106:2592-8. [PMID: 28089688 DOI: 10.1016/j.xphs.2017.01.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
29 Kovacsics D, Patik I, Özvegy-Laczka C. The role of organic anion transporting polypeptides in drug absorption, distribution, excretion and drug-drug interactions. Expert Opin Drug Metab Toxicol 2017;13:409-24. [PMID: 27783531 DOI: 10.1080/17425255.2017.1253679] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 7.2] [Reference Citation Analysis]
30 Johnson M, Patel D, Matheny C, Ho M, Chen L, Ellens H. Inhibition of Intestinal OATP2B1 by the Calcium Receptor Antagonist Ronacaleret Results in a Significant Drug-Drug Interaction by Causing a 2-Fold Decrease in Exposure of Rosuvastatin. Drug Metab Dispos 2016;45:27-34. [DOI: 10.1124/dmd.116.072397] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
31 Chow EC, Talattof A, Tsakalozou E, Fan J, Zhao L, Zhang X. Using Physiologically Based Pharmacokinetic (PBPK) Modeling to Evaluate the Impact of Pharmaceutical Excipients on Oral Drug Absorption: Sensitivity Analyses. AAPS J 2016;18:1500-11. [PMID: 27520379 DOI: 10.1208/s12248-016-9964-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
32 Rubinchik-Stern M, Shmuel M, Bar J, Eyal S, Kovo M. Maternal-fetal transfer of indocyanine green across the perfused human placenta. Reprod Toxicol 2016;62:100-5. [PMID: 27132189 DOI: 10.1016/j.reprotox.2016.04.017] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
33 Teja A, Musmade PB, Khade AB, Dengale SJ. Simultaneous improvement of solubility and permeability by fabricating binary glassy materials of Talinolol with Naringin: Solid state characterization, in-vivo in-situ evaluation. European Journal of Pharmaceutical Sciences 2015;78:234-44. [DOI: 10.1016/j.ejps.2015.08.002] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 5.3] [Reference Citation Analysis]
34 Mimura Y, Yasujima T, Ohta K, Inoue K, Yuasa H. Functional identification of organic cation transporter 1 as an atenolol transporter sensitive to flavonoids. Biochem Biophys Rep 2015;2:166-71. [PMID: 29124159 DOI: 10.1016/j.bbrep.2015.06.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
35 Margină D, Ilie M, Grădinaru D, Androutsopoulos VP, Kouretas D, Tsatsakis AM. Natural products-friends or foes? Toxicol Lett 2015;236:154-67. [PMID: 25980574 DOI: 10.1016/j.toxlet.2015.05.009] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 6.7] [Reference Citation Analysis]
36 Shen H, Su H, Liu T, Yao M, Mintier G, Li L, Fancher RM, Iyer R, Marathe P, Lai Y, Rodrigues AD. Evaluation of Rosuvastatin as an Organic Anion Transporting Polypeptide (OATP) Probe Substrate: In Vitro Transport and In Vivo Disposition in Cynomolgus Monkeys. J Pharmacol Exp Ther 2015;353:380-91. [DOI: 10.1124/jpet.114.221804] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
37 Nguyen M, Staubach P, Tamai I, Langguth P. High-dose short-term administration of naringin did not alter talinolol pharmacokinetics in humans. European Journal of Pharmaceutical Sciences 2015;68:36-42. [DOI: 10.1016/j.ejps.2014.12.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
38 O'Connor M, Lee C, Ellens H, Bentz J. A novel application of t-statistics to objectively assess the quality of IC50 fits for P-glycoprotein and other transporters. Pharmacol Res Perspect 2015;3:e00078. [PMID: 25692007 DOI: 10.1002/prp2.78] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
39 Stieger B, Hagenbuch B. Organic anion-transporting polypeptides. Curr Top Membr. 2014;73:205-232. [PMID: 24745984 DOI: 10.1016/b978-0-12-800223-0.00005-0] [Cited by in Crossref: 100] [Cited by in F6Publishing: 104] [Article Influence: 12.5] [Reference Citation Analysis]
40 Takahashi M, Onozawa S, Ogawa R, Uesawa Y, Echizen H. Predictive performance of three practical approaches for grapefruit juice-induced 2-fold or greater increases in AUC of concomitantly administered drugs. J Clin Pharm Ther 2015;40:91-7. [DOI: 10.1111/jcpt.12231] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
41 Nakanishi T, Tamai I. Putative roles of organic anion transporting polypeptides (OATPs) in cell survival and progression of human cancers: ROLE OF OATP IN CANCER CELLS. Biopharm Drug Dispos 2014;35:463-84. [DOI: 10.1002/bdd.1915] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
42 Nguyen M, Staubach P, Wolffram S, Langguth P. Effect of single-dose and short-term administration of quercetin on the pharmacokinetics of talinolol in humans – Implications for the evaluation of transporter-mediated flavonoid–drug interactions. European Journal of Pharmaceutical Sciences 2014;61:54-60. [DOI: 10.1016/j.ejps.2014.01.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
43 Sjögren E, Abrahamsson B, Augustijns P, Becker D, Bolger MB, Brewster M, Brouwers J, Flanagan T, Harwood M, Heinen C, Holm R, Juretschke H, Kubbinga M, Lindahl A, Lukacova V, Münster U, Neuhoff S, Nguyen MA, Peer AV, Reppas C, Hodjegan AR, Tannergren C, Weitschies W, Wilson C, Zane P, Lennernäs H, Langguth P. In vivo methods for drug absorption – Comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation/API/excipient characterization including food effects. European Journal of Pharmaceutical Sciences 2014;57:99-151. [DOI: 10.1016/j.ejps.2014.02.010] [Cited by in Crossref: 189] [Cited by in F6Publishing: 196] [Article Influence: 23.6] [Reference Citation Analysis]
44 Suzuki M, Komura H, Yoshikawa T, Enya S, Nagao A, Takubo H, Kogayu M. Characterization of gastrointestinal absorption of digoxin involving influx and efflux transporter in rats: application of mdr1a knockout (-/-) rats into absorption study of multiple transporter substrate. Xenobiotica 2014;44:1039-45. [PMID: 24839994 DOI: 10.3109/00498254.2014.920551] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
45 Shirasaka Y, Mori T, Murata Y, Nakanishi T, Tamai I. Substrate- and Dose-Dependent Drug Interactions with Grapefruit Juice Caused by Multiple Binding Sites on OATP2B1. Pharm Res 2014;31:2035-43. [DOI: 10.1007/s11095-014-1305-7] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 5.6] [Reference Citation Analysis]
46 Misaka S, Yatabe J, Müller F, Takano K, Kawabe K, Glaeser H, Yatabe MS, Onoue S, Werba JP, Watanabe H, Yamada S, Fromm MF, Kimura J. Green tea ingestion greatly reduces plasma concentrations of nadolol in healthy subjects. Clin Pharmacol Ther 2014;95:432-8. [PMID: 24419562 DOI: 10.1038/clpt.2013.241] [Cited by in Crossref: 89] [Cited by in F6Publishing: 93] [Article Influence: 11.1] [Reference Citation Analysis]
47 Hu S, Mathijssen RH, de Bruijn P, Baker SD, Sparreboom A. Inhibition of OATP1B1 by tyrosine kinase inhibitors: in vitro-in vivo correlations. Br J Cancer 2014;110:894-8. [PMID: 24398510 DOI: 10.1038/bjc.2013.811] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 4.8] [Reference Citation Analysis]
48 Ziberna L, Fornasaro S, Čvorović J, Tramer F, Passamonti S. Bioavailability of Flavonoids. Polyphenols in Human Health and Disease. Elsevier; 2014. pp. 489-511. [DOI: 10.1016/b978-0-12-398456-2.00037-2] [Cited by in Crossref: 16] [Article Influence: 2.0] [Reference Citation Analysis]
49 Ahmed IS, Hassan MA, Kondo T. Effect of lyophilized grapefruit juice on P-glycoprotein-mediated drug transport in-vitro and in-vivo. Drug Dev Ind Pharm 2015;41:375-81. [PMID: 24303901 DOI: 10.3109/03639045.2013.866141] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
50 Shirasaka Y, Shichiri M, Mori T, Nakanishi T, Tamai I. Major Active Components in Grapefruit, Orange, and Apple Juices Responsible for OATP2B1-Mediated Drug Interactions. Journal of Pharmaceutical Sciences 2013;102:3418-26. [DOI: 10.1002/jps.23653] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 4.6] [Reference Citation Analysis]
51 Shitara Y, Maeda K, Ikejiri K, Yoshida K, Horie T, Sugiyama Y. Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption. Biopharm Drug Dispos. 2013;34:45-78. [PMID: 23115084 DOI: 10.1002/bdd.1823] [Cited by in Crossref: 294] [Cited by in F6Publishing: 298] [Article Influence: 32.7] [Reference Citation Analysis]
52 Misaka S, Miyazaki N, Yatabe MS, Ono T, Shikama Y, Fukushima T, Kimura J. Pharmacokinetic and pharmacodynamic interaction of nadolol with itraconazole, rifampicin and grapefruit juice in healthy volunteers. J Clin Pharmacol 2013;53:738-45. [PMID: 23677858 DOI: 10.1002/jcph.95] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
53 Bentz J, O'Connor MP, Bednarczyk D, Coleman J, Lee C, Palm J, Pak YA, Perloff ES, Reyner E, Balimane P, Brännström M, Chu X, Funk C, Guo A, Hanna I, Herédi-Szabó K, Hillgren K, Li L, Hollnack-Pusch E, Jamei M, Lin X, Mason AK, Neuhoff S, Patel A, Podila L, Plise E, Rajaraman G, Salphati L, Sands E, Taub ME, Taur JS, Weitz D, Wortelboer HM, Xia CQ, Xiao G, Yabut J, Yamagata T, Zhang L, Ellens H. Variability in P-glycoprotein inhibitory potency (IC₅₀) using various in vitro experimental systems: implications for universal digoxin drug-drug interaction risk assessment decision criteria. Drug Metab Dispos 2013;41:1347-66. [PMID: 23620485 DOI: 10.1124/dmd.112.050500] [Cited by in Crossref: 125] [Cited by in F6Publishing: 126] [Article Influence: 13.9] [Reference Citation Analysis]
54 Takusagawa S, Ushigome F, Nemoto H, Takahashi Y, Li Q, Kerbusch V, Miyashita A, Iwatsubo T, Usui T. Intestinal absorption mechanism of mirabegron, a potent and selective β3-adrenoceptor agonist: involvement of human efflux and/or influx transport systems. Mol Pharm. 2013;10:1783-1794. [PMID: 23560393 DOI: 10.1021/mp300582s] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
55 Song IS, Choi MK, Shim WS, Shim CK. Transport of organic cationic drugs: effect of ion-pair formation with bile salts on the biliary excretion and pharmacokinetics. Pharmacol Ther 2013;138:142-54. [PMID: 23353097 DOI: 10.1016/j.pharmthera.2013.01.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
56 Lai Y. Organic anion-transporting polypeptides (OATPs/SLCOs). Transporters in Drug Discovery and Development 2013. [DOI: 10.1533/9781908818287.353] [Reference Citation Analysis]
57 Shirasaka Y, Shichiri M, Mori T, Nakanishi T, Tamai I. Major Active Components in Grapefruit, Orange, and Apple Juices Responsible for OATP2B1-Mediated Drug Interactions. Journal of Pharmaceutical Sciences 2013;102:280-8. [DOI: 10.1002/jps.23357] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 4.9] [Reference Citation Analysis]
58 Tamai I, Nakanishi T. Analysis of Intestinal Transporters. Transporters in Drug Development 2013. [DOI: 10.1007/978-1-4614-8229-1_8] [Reference Citation Analysis]
59 Kusuhara H, Yoshida K, Sugiyama Y. In Vivo Characterization of Interactions on Transporters. Transporters in Drug Development 2013. [DOI: 10.1007/978-1-4614-8229-1_4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
60 Shirasaka Y, Shichiri M, Murata Y, Mori T, Nakanishi T, Tamai I. Long-lasting inhibitory effect of apple and orange juices, but not grapefruit juice, on OATP2B1-mediated drug absorption. Drug Metab Dispos 2013;41:615-21. [PMID: 23264447 DOI: 10.1124/dmd.112.049635] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 4.0] [Reference Citation Analysis]
61 Dolton MJ, Roufogalis BD, McLachlan AJ. Fruit juices as perpetrators of drug interactions: the role of organic anion-transporting polypeptides. Clin Pharmacol Ther 2012;92:622-30. [PMID: 23033114 DOI: 10.1038/clpt.2012.159] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 5.0] [Reference Citation Analysis]
62 Yan M, Fang P, Li H, Xu P, Liu Y, Wang F, Cai H, Tan Q. Lack of effect of continuous glycyrrhizin administration on the pharmacokinetics of the P-glycoprotein substrate talinolol in healthy volunteers. Eur J Clin Pharmacol 2013;69:515-21. [DOI: 10.1007/s00228-012-1391-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
63 Roth M, Obaidat A, Hagenbuch B. OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies. Br J Pharmacol. 2012;165:1260-1287. [PMID: 22013971 DOI: 10.1111/j.1476-5381.2011.01724.x] [Cited by in Crossref: 502] [Cited by in F6Publishing: 520] [Article Influence: 50.2] [Reference Citation Analysis]
64 Arakawa H, Shirasaka Y, Haga M, Nakanishi T, Tamai I. Active intestinal absorption of fluoroquinolone antibacterial agent ciprofloxacin by organic anion transporting polypeptide, Oatp1a5: OATP-MEDIATED ABSORPTION OF CIPROFLOXACIN. Biopharm Drug Dispos 2012;33:332-41. [DOI: 10.1002/bdd.1809] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
65 Intestinal Transporters. Biopharmaceutics Modeling and Simulations 2012. [DOI: 10.1002/9781118354339.ch14] [Reference Citation Analysis]
66 Li J, Wang Y, Zhang W, Huang Y, Hein K, Hidalgo IJ. The role of a basolateral transporter in rosuvastatin transport and its interplay with apical breast cancer resistance protein in polarized cell monolayer systems. Drug Metab Dispos 2012;40:2102-8. [PMID: 22855735 DOI: 10.1124/dmd.112.045666] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
67 Suzuki K, Shitara Y, Fukuda K, Horie T. Long-Lasting Inhibition of the Intestinal Absorption of Fexofenadine by Cyclosporin a in Rats. Journal of Pharmaceutical Sciences 2012;101:2606-15. [DOI: 10.1002/jps.23174] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
68 Iwanaga K, Arimune K, Miyazaki M, Shibano M, Taniguchi M, Baba K, Kakemi M. Effects of furanocoumarins in Kampo extract-based medicines on rat intestinal absorption of CYP3A and P-glycoprotein substrate drugs in vivo. Arch Pharm Res 2012;35:1055-64. [DOI: 10.1007/s12272-012-0613-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
69 Tamai I. Oral drug delivery utilizing intestinal OATP transporters. Adv Drug Deliv Rev 2012;64:508-14. [PMID: 21824501 DOI: 10.1016/j.addr.2011.07.007] [Cited by in Crossref: 123] [Cited by in F6Publishing: 126] [Article Influence: 12.3] [Reference Citation Analysis]
70 Lim TK. Citrus x aurantium Grapefruit Group. Edible Medicinal And Non-Medicinal Plants 2012. [DOI: 10.1007/978-94-007-4053-2_91] [Reference Citation Analysis]
71 Nakanishi T, Tamai I. Oral drug delivery targeting intestinal transporter. Official Journal of the Japan Society of Drug Delivery System 2012;27:350-360. [DOI: 10.2745/dds.27.350] [Reference Citation Analysis]
72 Chu X, Zhang Z, Yabut J, Horwitz S, Levorse J, Li XQ, Zhu L, Lederman H, Ortiga R, Strauss J. Characterization of multidrug resistance 1a/P-glycoprotein knockout rats generated by zinc finger nucleases. Mol Pharmacol. 2012;81:220-227. [PMID: 22049154 DOI: 10.1124/mol.111.074179] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 3.8] [Reference Citation Analysis]
73 Tachibana T, Kato M, Sugiyama Y. Prediction of Nonlinear Intestinal Absorption of CYP3A4 and P-Glycoprotein Substrates from their In Vitro Km Values. Pharm Res 2012;29:651-68. [DOI: 10.1007/s11095-011-0579-2] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
74 Shirasaka Y, Suzuki K, Nakanishi T, Tamai I. Differential Effect of Grapefruit Juice on Intestinal Absorption of Statins Due to Inhibition of Organic Anion Transporting Polypeptide and/or P-glycoprotein. Journal of Pharmaceutical Sciences 2011;100:3843-53. [DOI: 10.1002/jps.22586] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 4.5] [Reference Citation Analysis]
75 Shoaf SE, Mallikaarjun S, Bricmont P. Effect of grapefruit juice on the pharmacokinetics of tolvaptan, a non-peptide arginine vasopressin antagonist, in healthy subjects. Eur J Clin Pharmacol 2012;68:207-11. [DOI: 10.1007/s00228-011-1106-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
76 Varma MV, Rotter CJ, Chupka J, Whalen KM, Duignan DB, Feng B, Litchfield J, Goosen TC, El-Kattan AF. pH-sensitive interaction of HMG-CoA reductase inhibitors (statins) with organic anion transporting polypeptide 2B1. Mol Pharm. 2011;8:1303-1313. [PMID: 21710988 DOI: 10.1021/mp200103h] [Cited by in Crossref: 80] [Cited by in F6Publishing: 83] [Article Influence: 7.3] [Reference Citation Analysis]
77 Sekine T, Kusuhara H. Organic Anion and Cation Drug Transporters. Oral Bioavailability 2011. [DOI: 10.1002/9781118067598.ch19] [Reference Citation Analysis]
78 Tapaninen T, Neuvonen PJ, Niemi M. Orange and apple juice greatly reduce the plasma concentrations of the OATP2B1 substrate aliskiren. Br J Clin Pharmacol 2011;71:718-26. [PMID: 21204914 DOI: 10.1111/j.1365-2125.2010.03898.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 76] [Article Influence: 6.7] [Reference Citation Analysis]
79 Wakuda H, Nejime N, Tada Y, Kagota S, Fahmi OA, Umegaki K, Yamada S, Shinozuka K. A novel method using confocal laser scanning microscopy for sensitive measurement of P-glycoprotein-mediated transport activity in Caco-2 cells. J Pharm Pharmacol 2011;63:1015-21. [PMID: 21718284 DOI: 10.1111/j.2042-7158.2011.01294.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
80 Catalán-latorre A, Nácher A, Merino V, Jiménez-torres NV, Merino-sanjuán M. In Situ Study of the Effect of Naringin, Talinolol and Protein-Energy Undernutrition on Intestinal Absorption of Saquinavir in Rats: UNDERNUTRITION AND INTERACTIONS ON SAQUINAVIR ABSORPTION. Basic & Clinical Pharmacology & Toxicology 2011;109:245-52. [DOI: 10.1111/j.1742-7843.2011.00714.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
81 Won CS, Oberlies NH, Paine MF. Influence of dietary substances on intestinal drug metabolism and transport. Curr Drug Metab 2010;11:778-92. [PMID: 21189136 DOI: 10.2174/138920010794328869] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
82 Seden K, Dickinson L, Khoo S, Back D. Grapefruit-drug interactions. Drugs. 2010;70:2373-2407. [PMID: 21142260 DOI: 10.2165/11585250-000000000-00000] [Cited by in Crossref: 106] [Cited by in F6Publishing: 110] [Article Influence: 9.6] [Reference Citation Analysis]
83 Bailey DG. Fruit juice inhibition of uptake transport: a new type of food-drug interaction. Br J Clin Pharmacol 2010;70:645-55. [PMID: 21039758 DOI: 10.1111/j.1365-2125.2010.03722.x] [Cited by in Crossref: 161] [Cited by in F6Publishing: 170] [Article Influence: 14.6] [Reference Citation Analysis]
84 Roth M, Timmermann BN, Hagenbuch B. Interactions of green tea catechins with organic anion-transporting polypeptides. Drug Metab Dispos. 2011;39:920-926. [PMID: 21278283 DOI: 10.1124/dmd.110.036640] [Cited by in Crossref: 143] [Cited by in F6Publishing: 150] [Article Influence: 13.0] [Reference Citation Analysis]
85 Hanley MJ, Cancalon P, Widmer WW, Greenblatt DJ. The effect of grapefruit juice on drug disposition. Expert Opin Drug Metab Toxicol 2011;7:267-86. [PMID: 21254874 DOI: 10.1517/17425255.2011.553189] [Cited by in Crossref: 138] [Cited by in F6Publishing: 143] [Article Influence: 12.5] [Reference Citation Analysis]
86 Tamai I. Oral Drug Delivery by Activation of Peptide Transporter PEPT1. MEMBRANE 2011;36:163-170. [DOI: 10.5360/membrane.36.163] [Reference Citation Analysis]
87 Oswald S, Terhaag B, Siegmund W. In Vivo Probes of Drug Transport: Commonly Used Probe Drugs to Assess Function of Intestinal P-glycoprotein (ABCB1) in Humans. In: Fromm MF, Kim RB, editors. Drug Transporters. Berlin: Springer Berlin Heidelberg; 2011. pp. 403-47. [DOI: 10.1007/978-3-642-14541-4_11] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
88 Kato K, Shirasaka Y, Kuraoka E, Kikuchi A, Iguchi M, Suzuki H, Shibasaki S, Kurosawa T, Tamai I. Intestinal absorption mechanism of tebipenem pivoxil, a novel oral carbapenem: involvement of human OATP family in apical membrane transport. Mol Pharm 2010;7:1747-56. [PMID: 20735088 DOI: 10.1021/mp100130b] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 4.7] [Reference Citation Analysis]
89 Shirasaka Y, Suzuki K, Nakanishi T, Tamai I. Intestinal Absorption of HMG-CoA Reductase Inhibitor Pravastatin Mediated by Organic Anion Transporting Polypeptide. Pharm Res 2010;27:2141-9. [DOI: 10.1007/s11095-010-0216-5] [Cited by in Crossref: 65] [Cited by in F6Publishing: 57] [Article Influence: 5.4] [Reference Citation Analysis]
90 Kagan L, Dreifinger T, Mager DE, Hoffman A. Role of P-Glycoprotein in Region-Specific Gastrointestinal Absorption of Talinolol in Rats. Drug Metab Dispos 2010;38:1560-6. [DOI: 10.1124/dmd.110.033019] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
91 Tamai I. Transporter-targeted oral drug delivery. Official Journal of the Japan Society of Drug Delivery System 2010;25:375-383. [DOI: 10.2745/dds.25.375] [Reference Citation Analysis]